With a global team of intra and entrepreneurs they are enabling positive disruption in the digital health and care industry through partnerships with rising health-tech companies. The Bayer G4A program is a great example of this. Partnerships between traditional health and digital health companies may not sound that ground-breaking, but in fact they can create tremendous commercial synergy. So, the pressure is on from a wave of competition in this historically entrenched industry. Consumer tech giants the likes of Google, Apple, and Amazon are all investing heavily into AI focused health services as a core part of their business. The strategy is to seek partnerships with emerging health-tech companies, and for good reason too. Secondly, major players in the traditional health sector are adopting a fresh innovative approach to expanding their healthcare services.
It is their combined expertise and collaboration which is laying the groundwork and quickly paving the way for this new industry.
The DTA is a coalition of 30+ corporate leaders in digital health, which NeuroTracker became a member of in 2018. This is set to change due to two key reasons.įirstly, the Digital Therapeutics Alliance (DTA) is now making great strides to build out the regulatory framework and standards of efficacy for the digital industry. As covered in a recent article, when it comes to harnessing digital solutions coming out of the tech industry, the health industry has long been stymied with regulatory challenges, inertia, and knowledge gaps.
0 kommentar(er)
